In Stock
Brilinta is a medication for people who have had a heart attack, and it’s been proven to significantly lower the risk of having another heart attack.
Ticagrelor, sold under the brand name Brilinta among others, is a medication used for the prevention of stroke, heart attack and other events in people with acute coronary syndrome, meaning problems with blood supply in the coronary arteries. It acts as a platelet aggregation inhibitor by antagonising the P2Y12 receptor. The drug is produced by AstraZeneca.
Origin
Made in Sweden, imported from Turkey
Brand
Active Substance
TicagrelorUses
- Reduce the risk of stroke in people with acute ischemic stroke or high-risk transient ischemic attack
- Prevention of stroke or heart attack or other events in people with acute coronary syndrome